Kiniksa Pharmaceuticals to Present at Canaccord Genuity 46th Annual Growth Conference

Rhea-AI Summary

Kiniksa Pharmaceuticals (Nasdaq: KNSA) announced that its management will participate in a fireside chat at the Canaccord Genuity 46th Annual Growth Conference on Wednesday, August 12, 2026 at 9:00 a.m. Eastern Time. A live webcast and replay will be available in the Investors section of Kiniksa’s website.

Market Context

KNSA's prior conference announcement had a 0.1% 24-hour price reaction, while the current notice pro...

Analysis

KNSA's prior conference announcement had a 0.1% 24-hour price reaction, while the current notice provides scheduling details rather than new operating results. The platform record adds limited event-specific evidence; recent insider Net Selling is a risk to monitor.

Key Figures

Conference edition: 46th annual Presentation date: August 12, 2026 Presentation time: 9:00 a.m. Eastern Time +1 more

4 metrics

Conference edition 46th annual Canaccord Genuity Growth Conference

Presentation date August 12, 2026 Scheduled fireside chat

Presentation time 9:00 a.m. Eastern Time August 12, 2026

Replay timing 48 hours After the event

Historical Context

5 past events · Latest: Jul 28 (Positive)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Jul 28	Q2 earnings report	Positive	+25.0%	Reported Q2 revenue growth, higher net income, and raised full-year ARCALYST guidance.
Jul 23	Earnings date notice	Neutral	-0.3%	Announced the date and webcast logistics for upcoming second-quarter results.
May 29	Conference presentations	Neutral	+0.1%	Announced two scheduled healthcare conference fireside chats and webcast availability.
Apr 28	Q1 earnings report	Positive	+23.5%	Reported revenue growth, higher net income, and increased full-year ARCALYST guidance.
Apr 23	Earnings date notice	Neutral	-0.6%	Announced the date and webcast logistics for upcoming first-quarter results.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

KNSA's recent earnings reports produced strong positive reactions, while earnings-date notices were negative and the prior conference announcement was nearly unchanged.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

LONDON, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will participate in a fireside chat at the Canaccord Genuity 46^th Annual Growth Conference on Wednesday, August 12, 2026 at 9:00 a.m. Eastern Time.

A live webcast of Kiniksa’s presentation will be accessible through the Investors section of the company’s website at www.kiniksa.com. A replay of the event will also be available on Kiniksa’s website within approximately 48 hours after the event.

About Kiniksa
Kiniksa is a biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating diseases by discovering, acquiring, developing, and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications. Kiniksa’s portfolio of assets is based on strong biologic rationale or validated mechanisms and offers the potential for differentiation. For more information, please visit www.kiniksa.com.

Every Second Counts! ^®

Kiniksa Investor & Media Contact
Jonathan Kirshenbaum
(781) 829-3949
jkirshenbaum@kiniksa.com

FAQ

When will Kiniksa Pharmaceuticals (KNSA) present at the Canaccord Genuity 46th Annual Growth Conference?

Kiniksa Pharmaceuticals will present at the Canaccord Genuity 46th Annual Growth Conference on Wednesday, August 12, 2026 at 9:00 a.m. Eastern Time. According to Kiniksa, the session will feature a management fireside chat accessible via live webcast on the company’s investor website.

How can investors access the Kiniksa (KNSA) webcast for the Canaccord Genuity 2026 conference presentation?

Investors can access Kiniksa’s live webcast through the Investors section of www.kiniksa.com. According to Kiniksa, the company will stream the fireside chat in real time and provide an online replay on the same site after the event for on-demand viewing.

Will a replay of Kiniksa’s August 12, 2026 Canaccord Genuity conference presentation be available to KNSA shareholders?

Yes, a replay of Kiniksa’s conference presentation will be available on the company’s website. According to Kiniksa, the replay is expected to be posted within approximately 48 hours after the August 12, 2026 fireside chat in the Investors section.

What does Kiniksa Pharmaceuticals (KNSA) focus on in its biopharmaceutical portfolio?

Kiniksa focuses on discovering, acquiring, developing, and commercializing novel therapies for diseases with unmet need, emphasizing cardiovascular indications. According to Kiniksa, its portfolio is built on strong biologic rationale or validated mechanisms and is designed to offer potential differentiation for patients with debilitating conditions.